High RPMB predicts poor disease-free survival of male N1 papillary thyroid cancer after adjuvant radioiodine therapy.

Heliyon · 2022 · PMC9708696 · PMID 36468103

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

very close to significancep = 0.062so close (0.05 < p ≤ 0.1)

Moreover, Kaplan–Meier analysis showed that high RPMBs could significantly predict poor DFS in male patients after R0 resection for N1 disease (HR: 5.431, 95% CI: 1.045–28.219, p = 0.024), and the p -value was very close to significance in these patients after adjuvant RAI therapy (HR: 6.269, 95% CI: 0.693–56.714, p = 0.062).

also in 191 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.